Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) EBT (2016 - 2020)

Historic EBT for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$9.4 million.

  • Forte Biosciences' EBT rose 4500.7% to -$9.4 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$55.8 million, marking a year-over-year decrease of 848.41%. This contributed to the annual value of -$63.5 million for FY2019, which is 3440.62% down from last year.
  • Forte Biosciences' EBT amounted to -$9.4 million in Q1 2020, which was up 4500.7% from -$10.6 million recorded in Q4 2019.
  • Over the past 5 years, Forte Biosciences' EBT peaked at $1.1 million during Q3 2018, and registered a low of -$19.4 million during Q4 2018.
  • Its 5-year average for EBT is -$11.3 million, with a median of -$10.0 million in 2017.
  • Its EBT has fluctuated over the past 5 years, first surged by 11131.32% in 2018, then crashed by 176385.44% in 2019.
  • Over the past 5 years, Forte Biosciences' EBT (Quarter) stood at -$8.5 million in 2016, then fell by 28.08% to -$10.8 million in 2017, then crashed by 79.15% to -$19.4 million in 2018, then soared by 45.49% to -$10.6 million in 2019, then rose by 11.23% to -$9.4 million in 2020.
  • Its last three reported values are -$9.4 million in Q1 2020, -$10.6 million for Q4 2019, and -$18.7 million during Q3 2019.